Stenting for Esophageal Varices: Treatment Options and Recommendations
Self-expandable metal stents (SEMS) can be used as a rescue therapy for refractory esophageal variceal bleeding, but they are not recommended as a primary treatment option for esophageal varices. The primary treatments remain endoscopic variceal ligation (EVL) and transjugular intrahepatic portosystemic shunt (TIPS).
Primary Management of Esophageal Varices
First-Line Therapy
- Endoscopic Variceal Ligation (EVL): Recommended as the primary endoscopic treatment for acute esophageal variceal bleeding 1
- Pharmacological Therapy: Vasoactive agents (terlipressin, somatostatin, or octreotide) should be initiated as soon as possible after admission 1
- Combined Approach: Combination of endoscopic and pharmacological therapy is superior to either treatment alone, with 5-day hemostasis rates of 77% vs. 58% for endoscopy alone 1
For Refractory Bleeding
When first-line therapy fails to control bleeding, the following options should be considered:
TIPS (Transjugular Intrahepatic Portosystemic Shunt):
- Recommended as the best rescue treatment for patients with inadequate bleeding control despite combined pharmacological and endoscopic therapy 1
- Achieves control of bleeding in approximately 90% of patients 1
- Early TIPS (within 72 hours, ideally <24 hours) should be considered in high-risk patients (Child-Pugh class B with active bleeding or Child-Pugh class C with MELD <14) 1
- Covered stents are now standard practice due to significantly improved patency rates 1
Self-Expandable Metal Stents (SEMS):
- Can be used as a bridge therapy when standard treatments fail 2, 3
- Initial bleeding control rate after SEMS application is approximately 100% 2
- Provides a safer alternative to balloon tamponade with better control of bleeding (85% vs. 47%) and fewer serious adverse events (15% vs. 47%) 4
- Can remain in place for up to 2 weeks 1
- May be considered for definitive treatment in patients with limited life expectancy or those unsuitable for TIPS 5
Balloon Tamponade:
Limitations and Complications
TIPS Complications
- Hepatic encephalopathy (15-25% of patients) 1
- Risk of hepatic decompensation due to diversion of portal flow 1
- Not recommended where the Child-Pugh score is >13 1
SEMS Complications
- Stent migration/dislocation (reported in up to 63.6% of cases) 2
- May require multiple procedures for placement and removal
Decision Algorithm
Initial Management:
- Start vasoactive drugs immediately upon suspicion of variceal bleeding
- Perform endoscopic therapy (preferably EVL) once patient is stable
- Add antibiotic prophylaxis
If Bleeding Persists or Recurs Within 5 Days:
- For hemodynamically stable patients with Child's C disease (C10-13) or MELD ≥19: Consider early TIPS within 72 hours
- For other patients with refractory bleeding: Consider rescue TIPS
If TIPS is Contraindicated or Not Immediately Available:
- Consider SEMS as a bridge therapy (can remain in place for up to 2 weeks)
- SEMS is preferable to balloon tamponade due to better efficacy and safety profile
For Long-Term Management:
- TIPS with covered stents for patients who have failed endoscopic and pharmacological therapy
- SEMS may be considered as definitive treatment only in patients with limited life expectancy or those unsuitable for TIPS
Important Considerations
- Stent migration is common with SEMS (63.6%) but doesn't necessarily lead to rebleeding 2
- TIPS should be performed with covered stents due to superior patency rates 1
- The goal portal pressure gradient after TIPS should be <12 mmHg 6
- Concurrent obliteration of varices is recommended during TIPS creation 6
In conclusion, while stenting with SEMS can be an effective rescue therapy for refractory esophageal variceal bleeding, it is primarily used as a bridge to more definitive treatment (usually TIPS) rather than as a primary treatment option for esophageal varices.